🕐16.12.11 - 19:27 Uhr

MID-DAY BREAKING NEWS FROM ALMADEN MINERALS AND TRIMEL PHARMACEUTICALS



Add to your address book or safe list to ensure delivery of email blasts (click for instructions)


Get Real-Time Quote
Almaden Hits 28.96 m of 2.44 g/t Au and 103.1 g/t Ag (4.5 g/t AuEq) on Main Ixtaca Zone
16 Dec 2011
Almaden Minerals Ltd. is pleased to announce results from the on-going drilling program on the Companys 100% owned Tuligtic project, Mexico with holes TU-11-68, 70 to 74 and 76, all drilled into the main Ixtaca Zone. Hole TU-11-74 was drilled along the SW extension of the Ixtaca zone and shows mineralisation to be continuing in this direction. Final analyses have not yet been received for holes TU-11-69 and 75. [View More]

Get Real-Time Quote
Trimel to Present Anorgasmia (FSD) Phase II Clinical Trial Results
16 Dec 2011
Trimel Pharmaceuticals Corporation today announced that it will present the results of its Phase II clinical study which measured parameters related to female orgasm at an upcoming Trimel R&D Event on February 14th, 2012 in Toronto. Trimels recently completed Phase II study measured the effect of its product TBS-2 in women experiencing Anorgasmia, a form of Female Sexual Dysfunction (FSD). [View More] VIEW MORE [+]

Disclaimer: Vantage Communications Ltd. was paid to distribute this bulletin. Vantage Communications may or may not own securities in this particular company. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! You are on this mailing list because you registered for VantageWire News. Past performance of Companies mentioned does not guarantee future performance.

If you would like to opt out click here.

For more information about this service, please contact:
Vantage Communications Ltd. at 1.800.574.0901, Suite 150 - 666 Burrard St, Vancouver, British Columbia V6C 2X8, This email complies with the US Federal CAN-SPAM Act of 2003




Products & Services | Jobs